Leadership team

Andy Weymann MD

Chief Executive Officer & Director of the Board

Andy is an orthopedic surgeon with 25 years of experience in global executive and board roles in medical device and regenerative medicine organizations. He holds a Masters in Human Medicine (University of Zurich), an MBA degree (Simon School of Business, University of Rochester) and has attended the board program at Harvard Business School. Andy was previously CMO of Smith+Nephew, Board Member of S+N Switzerland and other boards. He also led AO Education, including specifically AOSpine.

Cristin Taylor

Cristin Taylor

Senior Vice President Clinical and Medical Affairs

Cristin is a trained physiotherapist and licensed physician assistant with 10 years of clinical experience prior to moving to industry. She has worked at Smith and Nephew leading global clinical strategy and is presently leading clinical strategy for Beckman Coulter in the development of a machine learning algorithm for in-vitro diagnostics applications. Cristin has a Doctorate of Physical therapy (DPT) from the University of Miami, a MSHS from the George Washington University, and a BS from Boston University.


Michelle Lee

Senior Vice President Process and Compliance

Michelle has worked as a pharmaceutical professional in leading multi-national pharmaceutical and medical devices companies, as well as small/start-ups globally for the past 20 years. She brings extensive experience in product development, product transfer, manufacturing, process/system validation and supplier audit. Michelle graduated with a BSc. in Chemistry (with 2-year undergraduate research in Biochemistry granted by NIH) from The Ohio State University.


Nana Owusu

Nana Owusu-Koduah

Senior Vice President Quality Assurance

Over the last 15 years, Nana has worked for global pharmaceutical and contract research organisations. He has held roles in product development, quality control, quality assurance and production/operations. Nana holds a BSc in Pharmaceutical & Chemical Science from Liverpool John Moores University and an MBA degree from Bradford School of Management. He is also recognised as a Chartered Manager with the Chartered Management Institute (CMI). He brings significant experience and expertise in operations and quality management.

Oliver Schofield

Chief Financial Officer

Oliver has raised investment for multiple biotech start-ups and previously worked in management consulting at KPMG, focusing on finance transformation with large pharma. Oliver has a MSc in Bioscience Enterprise from the University of Cambridge and is a member of the Chartered Institute of Management Accounts.

Philippe Jenny MD

Chief Innovation Officer & Executive Director

Philippe is a medical doctor trained in spine surgery with an impressive career in the development and commercialisation of innovative devices to treat spinal and other conditions. He’s worked specially at Sofamor-Stryker Spine and on numerous other assignments, such as Solvay, Spinplant, Centest and Innospine.

Board of directors

Michael Fiore

Chairman

Michael has more than 37 years of experience in the Health Care Services, Technology and Medical Device Industry. He holds an MBA from Harvard University, an MSc in Accounting (NYU) and a BA in Economics and Anthropology (Amherst College). Mike is the Co-Founder and CEO of Vantage Oncology LLC. Mike is also Chairman of California Cryobank and Infusion Express, and serves as a Partner at Linden LLC, a healthcare private equity firm.

Sam Bakri MD

Vice Chairman

Sam is a serial healthcare entrepreneur and is notably Co-Founder and former CEO of Kind Consumer. He is Founder and Executive Chairman at biotech company Solascure. He has been involved in numerous ventures, and has a background in the pharmaceutical industry. He holds a medical degree from the University of London and an MBA from Harvard Business School where he was a Fulbright Scholar.

Andy Weymann MD

Chief Executive Officer & Director of the Board

Andy is an orthopedic surgeon with 25 years of experience in global executive and board roles in medical device and regenerative medicine organizations. He holds a Masters in Human Medicine (University of Zurich), an MBA degree (Simon School of Business, University of Rochester) and has attended the board program at Harvard Business School. Andy was previously CMO of Smith+Nephew, Board Member of S+N Switzerland and other boards. He also led AO Education, including specifically AOSpine.

Philippe Jenny MD

Chief Innovation Officer & Executive Director

Philippe is a medical doctor trained in spine surgery with an impressive career in the development and commercialisation of innovative devices to treat spinal and other conditions. He’s worked specially at Sofamor-Stryker Spine and on numerous other assignments, such as Solvay, Spinplant, Centes and Innospine.

Prof Tony Freemont

Co-Founder, Director

Tony is a Professor in Osteoarticular Pathology, Lead Pathologist and Deputy Director at Central Manchester University NHS Trust, NED at Christie NHS Trust, head of the Medical Education and School of Biomedicine at Manchester Medical School. Tony is the inventor of the DXM technology, academic co-founder and former Chairman of Gelmetix (previously Gelexir Healthcare).

Gerard De Geer

Director

Gerard De Geer currently serves as Senior Adviser of IK Investment Partners. He previously spent 9 years with the firm as a Partner in Strategy, Operations and Business Control. Prior to this Gerard spent eight years as a Vice President at A.T. Kearney in Stockholm and spent 12 years working in general management positions in the manufacturing industry. He serves as the Chairman and board member of several companies and is a seasoned investor.

Navin Khattar

Director

Navin Khattar is the Executive director with a global investment company. He is also Non-Executive Director of a global education service provider listed on AIM. Navin is a qualified solicitor of the Law Society of England & Wales and previously practised within the City of London, specialising in corporate finance. He holds an LLB (Hons) degree from the University of Bristol.